| Effect of particle diameter and surface composition on the spontaneous fusion of monolayer-protected gold nanoparticles with lipid bilayers RC Van Lehn, PU Atukorale, RP Carney, YS Yang, F Stellacci, DJ Irvine, ... Nano letters 13 (9), 4060-4067, 2013 | 273 | 2013 |
| High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry YSS Yang, PU Atukorale, KD Moynihan, A Bekdemir, K Rakhra, L Tang, ... Nature communications 8 (1), 14069, 2017 | 126 | 2017 |
| Oligonucleotide delivery by cell-penetrating “striped” nanoparticles CM Jewell, JM Jung, PU Atukorale, RP Carney, F Stellacci, DJ Irvine Angewandte Chemie (International ed. in English) 50 (51), 12312, 2011 | 91 | 2011 |
| Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core− shell gel particles Y Hu, PU Atukorale, JJ Lu, JJ Moon, SH Um, EC Cho, Y Wang, J Chen, ... Biomacromolecules 10 (4), 756-765, 2009 | 84 | 2009 |
| Vascular targeting of nanoparticles for molecular imaging of diseased endothelium PU Atukorale, G Covarrubias, L Bauer, E Karathanasis Advanced drug delivery reviews 113, 141-156, 2017 | 81 | 2017 |
| Nanoparticle encapsulation of synergistic immune agonists enables systemic codelivery to tumor sites and IFNβ-driven antitumor immunity PU Atukorale, SP Raghunathan, V Raguveer, TJ Moon, C Zheng, ... Cancer research 79 (20), 5394-5406, 2019 | 64 | 2019 |
| Influence of the glycocalyx and plasma membrane composition on amphiphilic gold nanoparticle association with erythrocytes PU Atukorale, YS Yang, A Bekdemir, RP Carney, PJ Silva, N Watson, ... Nanoscale 7 (26), 11420-11432, 2015 | 60 | 2015 |
| Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors ME Lorkowski, PU Atukorale, PA Bielecki, KH Tong, G Covarrubias, ... Journal of controlled release 330, 1095-1105, 2021 | 42 | 2021 |
| Structure–property relationships of amphiphilic nanoparticles that penetrate or fuse lipid membranes PU Atukorale, ZP Guven, A Bekdemir, RP Carney, RC Van Lehn, DS Yun, ... Bioconjugate chemistry 29 (4), 1131-1140, 2018 | 39 | 2018 |
| Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors PA Bielecki, ME Lorkowski, WM Becicka, PU Atukorale, TJ Moon, Y Zhang, ... Nanoscale horizons 6 (2), 156-167, 2021 | 36 | 2021 |
| Stimuli‐Responsive iron oxide nanotheranostics: A versatile and powerful approach for cancer therapy ME Lorkowski, PU Atukorale, KB Ghaghada, E Karathanasis Advanced healthcare materials 10 (5), 2001044, 2021 | 29 | 2021 |
| One-pot synthesis of nanochain particles for targeting brain tumors VS Perera, G Covarrubias, M Lorkowski, P Atukorale, A Rao, ... Nanoscale 9 (27), 9659-9667, 2017 | 23 | 2017 |
| The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment WM Becicka, PA Bielecki, ME Lorkowski, TJ Moon, Y Zhang, PU Atukorale, ... Nanoscale Advances 3 (17), 4961-4972, 2021 | 18 | 2021 |
| Dual agonist immunostimulatory nanoparticles combine with PD1 blockade for curative neoadjuvant immunotherapy of aggressive cancers PU Atukorale, TJ Moon, AR Bokatch, CF Lusi, JT Routhier, VJ Deng, ... Nanoscale 14 (4), 1144-1159, 2022 | 11 | 2022 |
| Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer G Covarrubias, TJ Moon, G Loutrianakis, HM Sims, MP Umapathy, ... Journal of Materials Chemistry B 10 (2), 224-235, 2022 | 9 | 2022 |
| Methotrexate suppresses psoriatic skin inflammation by inhibiting muropeptide transporter SLC46A2 activity R Bharadwaj, CF Lusi, S Mashayekh, A Nagar, M Subbarao, GI Kane, ... Immunity 56 (5), 998-1012. e8, 2023 | 8 | 2023 |
| Erratum: High-throughput quantitation of inorganic nanoparticle biodistribution at the single-cell level using mass cytometry YSS Yang, PU Atukorale, KD Moynihan, A Bekdemir, K Rakhra, L Tang, ... Nature communications 8, 2017 | 3 | 2017 |
| Nanoparticle delivery of innate immune agonists combines with senescence-inducing agents to mediate T cell control of pancreatic cancer L Chibaya, CF Lusi, KD DeMarco, GI Kane, ML Brassil, CN Parikh, ... bioRxiv, 2023 | 1 | 2023 |
| Methotrexate inhibition of muropeptide transporter SLC46A2 controls psoriatic skin inflammation R Bharadwaj, CF Lusi, S Mashayekh, A Nagar, M Subbarao, GI Kane, ... bioRxiv, 2022.09. 29.509906, 2022 | 1 | 2022 |
| Multi-component nanoconstructs E Karathanasis, WPM Peiris, E Doolittle US Patent 10,729,652, 2020 | 1 | 2020 |
Darrell J. IrvineMassachusetts Institute of TechnologyVerified email at mit.edu
